Medical Imaging (MEDD) 10-Q 14 May 14 2014 Q1 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	3 Months Ended
	Mar. 31, 2014	14-May-14
Document And Entity Information	'	'
Entity Registrant Name	'DIAGNOSTIC IMAGING INTERNATIONAL CORP	'
Entity Central Index Key	'0001370804	'
Document Type	'10-Q	'
Document Period End Date	31-Mar-14	'
Amendment Flag	'false	'
Current Fiscal Year End Date	'--12-31	'
Is Entity a Well-known Seasoned Issuer?	'No	'
Is Entity a Voluntary Filer?	'No	'
Is Entity's Reporting Status Current?	'Yes	'
Entity Filer Category	'Smaller Reporting Company	'
Entity Common Stock, Shares Outstanding	'	23,726,481
Document Fiscal Period Focus	'Q1	'
Document Fiscal Year Focus	'2014	'

Consolidated_Balance_Sheets_Un

Consolidated Balance Sheets (Unaudited) (USD $)	Mar. 31, 2014	Dec. 31, 2013
Current Assets	'	'
Cash and Cash Equivalents	$323,622	$77,300
Accounts Receivable, net	295,507	295,614
Prepaid Expenses	8,584	5,364
Total Current Assets	627,713	378,278
Property and Equipment	'	'
Equipment	1,433,707	1,437,464
Less: Accumulated Depreciation	-275,028	-237,763
Total Property and Equipment, net	1,158,679	1,199,701
Intangibles	'	'
Hospital Contracts	524,585	794,707
Non-Compete Contract	133,245	133,245
Less: Accumulated Amortization	-657,830	-905,027
Total Intangible Assets, net	0	22,925
Goodwill	1,422,670	1,422,670
Other Assets	'	'
Deposits	12,677	12,855
Loans Receivable	1,766	2,046
Total Other Assets	14,443	14,901
TOTAL ASSETS	3,223,505	3,038,475
Current Liabilities	'	'
Accounts Payable	208,754	250,099
Accrued Taxes Payable	331,155	358,052
Obligations Under Capital Lease, short term portion	104,009	102,210
Acquisition Liability	200,000	200,000
Promissory Notes, short term portion	18,669	27,543
Convertible Notes, net short term portion	54,900	0
Total Current Liabilities	917,487	937,904
Long Term Liabilities	'	'
Obligations Under Capital Lease, long term portion	210,396	228,495
Promissory Notes, long-term portion	13,829	17,472
Convertible Notes, net, long term portion	2,097,614	1,856,869
Total Long Term Liabilities	2,321,839	2,102,836
Total Liabilities	3,239,326	3,040,740
Stockholders' Equity (Deficit)	'	'
Preferred Stock	0	0
Common Stock	23,727	23,422
Additional Paid-In Capital	1,862,424	1,837,079
Accumulated Other Comprehensive Gain	7,773	6,708
Accumulated Deficit	-1,909,745	-1,869,474
Total Stockholders' Equity (Deficit)	-15,821	-2,265
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$3,223,505	$3,038,475

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parenthetical) (USD $)	Mar. 31, 2014	Dec. 31, 2013
Statement of Financial Position [Abstract]	'	'
Preferred stock, par value in dollars	$0.00	$0.00
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value in dollars	$0.00	$0.00
Common stock, shares authorized	500,000,000	500,000,000
Common stock, shares issued	23,726,481	23,421,481
Common stock, shares outstanding	23,726,481	23,421,481

Consolidated_Statements_of_Ope

Consolidated Statements of Operations (Unaudited) (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Revenue:	'	'
Sales	$1,195,937	$1,299,005
Less: Cost of Sales	705,495	803,876
Gross Margin	490,442	495,129
Operating Expenses:	'	'
Advertising	16,523	1,417
Amortization	22,925	34,386
Depreciation	39,820	39,436
Bad Debt Expense (Recapture)	7,522	29,395
General and Administrative	54,523	45,984
Insurance	11,746	10,605
Labor	190,480	186,848
Legal and Professional	41,226	40,835
Management Fees	4,422	3,884
Rent Office Space and Servers	39,136	38,710
Travel	14,388	9,086
Total Operating Expenses	442,711	440,586
Income from Operations	47,731	54,543
Other Income and (Expenses):	'	'
Other Income	160	0
Debt Settlement Loss	0	-607
Foreign Currency Gains (Losses)	415	3,351
Amortization of Debt Discount	-20,356	-18,806
Interest Expense	-68,225	-70,511
Total Other Income (Expenses)	-88,006	-86,573
Income (Loss) Before Provision for Income Taxes	-40,275	-32,030
Provision for Income Taxes	0	0
Net Income (Loss)	-40,275	-32,030
Comprehensive Income (Loss)	1,065	1,387
Total Comprehensive Income (Loss)	($39,210)	($30,643)
Basic and Diluted Income (Loss) per Share	($0.00)	($0.00)
Weighted Average Shares Outstanding - Basic and Diluted	23,350,793	23,134,813

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (Unaudited) (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
CASH FLOWS FROM OPERATING ACTIVITIES:	'	'
Net Income (Loss)	($40,275)	($32,030)
Adjustments to Reconcile Net Loss to Net Cash provided by Operating Activities:	'	'
Depreciation	39,820	39,436
Asset Write Off	974	0
Accrued Interest Converted into note	61,832	58,412
Amortization of Debt Discount	20,356	18,806
Shares issued for services	150	0
Amortization of Intangible Assets	22,925	34,386
Foreign currency transaction Gain/ Loss	229	-2,750
Changes in operating assets and liabilities:	'	'
Accounts Receivable	107	32,536
Deposits and prepaid expenses	-3,042	3,167
Accounts Payable and accrued liabilities	-68,239	92,276
Loans Receivable	280	471
NET CASH AND CASH EQUIVALENTS PROVIDED BY OPERATING ACTIVITIES	35,117	244,710
CASH FLOWS FROM INVESTING ACTIVITIES:	'	'
Equipment Purchase	0	-10,000
NET CASH USED IN INVESTING ACTIVITIES	0	-10,000
CASH FLOWS FROM FINANCING ACTIVITIES	'	'
Proceeds from debt issuance	300,000	150,000
Principal payments on Related Party debt	0	-4,023
Principal payments on debt	-73,560	-112,789
Principal Payments on Capital Lease Obligations	-16,300	-146,925
NET CASH AND CASH EQUIVALENTS USED IN FINANCING ACTIVITIES	210,140	-113,737
Gain (Loss) due to foreign currency translation	1,065	1,387
NET CHANGE IN CASH AND CASH EQUIVALENTS	246,322	122,360
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD	77,300	107,701
CASH AND CASH EQUIVALENTS AT END OF PERIOD	323,622	230,061
Cash paid during the year for:	'	'
Interest	6,393	12,099
Income Taxes	18,900	11,400
Non-cash financing and investing activities:	'	'
Shares Issued for Convertible Note	$25,500	$18,600

Organization_and_Summary_of_Si

Organization and Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Organization and Summary of Significant Accounting Policies	'
	Note 1. Organization and Summary of Significant Accounting Policies
	Organization and Basis of Presentation
	Diagnostic Imaging International Corp., (“DIIC” or the “Company”) a Nevada Corporation, was incorporated in 2000. In 2005, the Company developed a business plan for private healthcare opportunities in Canada with the objective of owning and operating private diagnostic imaging clinics. In 2009, the Company purchased Custom Teleradiology Services, Inc. (“CTS”), a company that provides remote reading of diagnostic imaging scans for rural hospitals and clinics. In early 2010, the Company modified its business plan to grow its CTS subsidiary while commencing the acquisition of existing full service imaging clinics located in the United States and exploring the development of new diagnostic imaging technology. In 2012, the Company purchased Schuylkill Medical Imaging (“SMI”) an independent Magnetic Resonance Imaging (MRI) facility located in Pottsville, Pennsylvania.
	Basis of Presentation
	These consolidated financial statements and related notes are presented in accordance with accounting principles generally accepted in the United States, and are expressed in U.S. dollars. The Company’s fiscal year-end is December 31.
	Principle of Consolidation
	The consolidated financial statements include the accounts of Diagnostic Imaging International, Corp., and our wholly-owned subsidiaries, Canadian Teleradiology Services, Inc. and Schuylkill Open MRI, Inc. Intercompany accounts and transactions have been eliminated in the consolidated financial statements. CTS’ and SMI’s accumulated earnings prior to their acquisition (March 2, 2009 and December 10, 2012, respectively) are not included in the consolidated balance sheet.
	Reclassification of Accounts
	Certain prior period amounts have been reclassified to conform to the March 31, 2014 presentation.
	Use of Estimates and Assumptions
	The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States (“GAAP”) requires management to make estimates and assumptions that affect (i) the reported amounts of assets and liabilities, (ii) the disclosure of contingent assets and liabilities known to exist as of the date the consolidated financial statements are published, and (iii) the reported amount of net sales, expenses and costs recognized during the periods presented. Adjustments made with respect to the use of estimates often relate to improved information not previously available. Uncertainties with respect to such estimates and assumptions are inherent in the preparation of consolidated financial statements; accordingly, actual results could differ from these estimates.
	Cash and Cash Equivalents
	The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. At March 31, 2014, and December 31, 2013, cash includes cash on hand and cash in the bank.
	Accounts Receivable Credit Risk
	The allowance for doubtful accounts is maintained at a level sufficient to provide for estimated credit losses based on evaluating known and inherent risks in the receivables portfolio.
	Management evaluates various factors including expected losses and economic conditions to predict the estimated realization on outstanding receivables. As of March 31, 2014 and December 31, 2013, the allowance for bad debts was $24,816 and $17,294, respectively. Bad debt expense for the three months ended March 31, 2014 and 2013 was $7,522 and $29,395, respectively.
	At March 31, 2014 three customers of CTS totalled approximately 40% of the total accounts receivable. As of December 31, 2013, three customers totalled approximately 70% of the total accounts receivable.
	Goodwill and Indefinite Intangible Assets
	The Company follows the provisions of Financial Accounting Standard (“FASB”) Accounting Standards Codification (“ASC”) Topic 350, Goodwill and Other Intangible Assets. In accordance with ASC Topic 350, goodwill, representing the excess of the purchase price and related costs over the value assigned to net tangible and identifiable intangible assets of businesses acquired and accounted for under the purchase method, acquired in business combinations is assigned to reporting units that are expected to benefit from the synergies of the combination as of the acquisition date. Under this standard, goodwill and intangibles with indefinite useful lives are not amortized. The Company assesses goodwill and indefinite-lived intangible assets for impairment annually during the fourth quarter, or more frequently if events and circumstances indicate impairment may have occurred in accordance with ASC Topic 350. If the carrying value of a reporting unit's goodwill exceeds its implied fair value, the Company records an impairment loss equal to the difference. ASC Topic 350 also requires that the fair value of indefinite-lived purchased intangible assets be estimated and compared to the carrying value. The Company recognizes an impairment loss when the estimated fair value of the indefinite-lived purchased intangible assets is less than the carrying value. As of March 31, 2014, the Company has goodwill of $1,422,670 as result of the acquisition of SMI on December 10, 2012. If the implied fair value of goodwill is lower than its carrying amount, goodwill impairment is indicated and goodwill is written down to its implied fair value. Subsequent increases in goodwill value are not recognized in the consolidated financial statements.
	Intangible Assets
	CTS has contracts with various hospitals in the province of Ontario, Canada. These contracts are for specific radiology services to be provided for a length of time. Contracts varied between one and five years. The contracts do not specify any minimum billings for any period of time. The contracts in existence on acquisition were valued on acquisition using a discounted cash flow model and the fair value as recorded is amortized over the remaining life of the contract using the straight line method.
	The Company has written off one of the hospital contracts to reflect end of service with no potential for renewal.
	The Company also attributed value to the non-compete agreement obtained as part of the acquisition agreement with CTS’ former director. As of March 31, 2014. The value attributed to this agreement has been fully amortized.
	SMI has a non-compete agreement with previous owners of SMI. The value attributed to this agreement has been fully amortized.
	Amortization of Intangible Assets
	The accumulated amortization of intangible assets with finite useful lives was $657,830 and $905,027 in March 31, 2014 and December 31, 2013, respectively.
	These assets have been fully amortized; therefore there is no expected amortization expense for the next five years.
	Revenue Recognition
	The Company holds contracts with several hospitals and groups of health care facilities to provide Teleradiology services for a specific period of time. The Company bills for services rendered on a monthly basis. For the year ended December 31, 2013, CTS held seven contracts; one contract that is renewable on a year-to-year basis, four contracts that are renewable in 2014 ,2015, and 2016, and its two largest contracts, which renewed automatically in 2013 for successive one year terms. As described above, in accordance with the requirement of Staff Accounting Bulletin (“SAB”) 104, the Company recognizes revenue when: (1) persuasive evidence of an arrangement exists (contracts); (2) delivery has occurred (monthly); (3) the seller’s price is fixed or determinable (per the customer’s contract, and services performed); and (4) collectability is reasonably assured (based upon our credit policy).
	Revenue is accounted for under the guidelines established by SAB 101, Revenue Recognition in Financial Statements, and ASC Topic 605-45, Revenue Recognition – Principal Agent Considerations. For CTS, the Company has the following indicators of gross revenue reporting: (1) CTS is the primary obligator in the provision of services to the Hospitals under contract, (2) CTS has latitude in establishing price, and negotiating contracts with each hospital, (3) CTS negotiates and determines the service specification to be provided to each hospital client, (4) CTS has complete discretion in supplier selection, and (5) CTS has the credit risk. Accordingly, the Company records CTS revenue at gross.
	For SMI, revenue is recorded at the time of service.
	Cost of Sales
	Cost of sales includes fees paid to radiologists for teleradiology services, transcription fees, equipment repairs, system license and usage costs.
	Impairment of Long-Lived Assets
	In accordance with ASC Topic 360, Property, Plant and Equipment, property, plant, and equipment, and purchased intangibles are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Goodwill and other intangible assets are tested for impairment. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset.
	Amortization and Depreciation
	Depreciation and amortization are calculated using the straight-line method over the following useful lives:
	3 - 7 years Equipment
	5 – 7 years Furniture and Fixtures
	2 to 5 years Hospital Contracts
	3 - 5 years Non-compete Contract
	39 years Leasehold Improvements
	Stock Based Compensation
	The Company measures all share-based payments to employees (which includes non-employee Board of Directors), including employee stock options, warrants and restricted stock, at the fair value of the award and expenses it over the requisite service period (generally the vesting period). The fair value of common stock options or warrants granted to employees is estimated at the date of grant using the Black-Scholes option pricing model. The calculation also takes into account the common stock fair market value at the grant date, the exercise price, the expected life of the common stock option or warrant, the dividend yield and the risk-free interest rate.
	The Company from time to time may issue stock options, warrants and restricted stock to acquire goods or services from third parties. Restricted stock, options or warrants issued to other than employees or directors are recorded on the basis of their fair value. The options or warrants are valued using the Black-Scholes option pricing model on the basis of the market price of the underlying equity instrument on the “valuation date,” which for options and warrants related to contracts that have substantial disincentives to non-performance, is the date of the contract, and for all other contracts is the vesting date. Expenses related to the options and warrants are recognized on a straight-line basis over the period which services are to be received.
	The Company did not recognize stock-based compensation expenses from stock granted to non-employees for the three months ended March 31, 2014 and 2013.
	The Company recognized stock-based compensation expenses of $150, and $0 from stock granted to employees for the three months ended March 31, 2014, and 2013, respectively.
	Fair Value of Financial Instruments
	The fair value of a financial instrument is the amount at which the instrument could be exchanged in a current transaction between willing parties other than in a forced sale or liquidation.
	The carrying amounts of the Company’s financial instruments, including cash, accounts receivable, accounts payable and accrued liabilities and income taxes payable approximate fair value due to their most maturities.
	Fair Value Measurements
	The Company follows paragraph 825-10-50-10 of the FASB Accounting Standards Codification (“ASC”) for disclosures about fair value of its financial instruments and paragraph 820-10-35-37 of the FASB ASC (“Paragraph 820-10-35-37”) to measure the fair value of its financial instruments. Paragraph 820-10-35-37 establishes a framework for measuring fair value in U.S. GAAP, and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, Paragraph 820-10-35-37 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The three levels of fair value hierarchy defined by Paragraph 820-10-35-37 are described below:
	Level 1 Quoted market prices available in active markets for identical assets or liabilities as of the reporting date.
	Level 2 Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date.
	Level 3 Pricing inputs that are generally observable inputs and not corroborated by market data.
	The carrying amounts of the Company’s financial assets and liabilities, such as cash and accounts payable approximate their fair values because of the short maturity of these instruments.
	The company does not have assets and liabilities that are carried at fair value on a recurring basis.
	The Company’s functional currency for its wholly-owned subsidiary, CTS, is the Canadian dollar, and their financial statements have been translated into U.S. dollars. The Canadian dollar based accounts of the Company’s foreign operations have been translated into United States dollars using the current rate method. Assets and liabilities of those operations are translated into U.S. dollars using exchange rates as of the balance sheet date; income and expenses are translated using the weighted average exchange rates for the reporting period. Translation adjustments are recorded as accumulated other comprehensive income (loss), a separate component of stockholders’ equity.
	The Company recognized a foreign currency gain on transactions from operations of $415 and $3,351 for the three months ended March 31, 2014 and 2013, respectively.
	The Company recognized other comprehensive income of $1,065 and $1,387 for the three months ended March 31, 2014 and 2013, respectively.
	Income Taxes
	The Company accounts for income taxes in accordance with ASC Topic 740, Income Taxes. This statement prescribes the use of the asset and liability method whereby deferred tax asset and liability account balances are determined based on differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse.
	Net Income (Loss) Per Share
The Company follows the provisions of ASC Topic 260, Earnings per Share. Basic net income (loss) per share is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding during the period. Basic and diluted losses per share are the same as all potentially dilutive securities are anti-dilutive.
Basic earnings per share is computed by dividing net income available to common shareholders by the weighted average number of common shares outstanding during the period. Diluted earnings per share reflects the potential dilution that could occur if stock options and other commitments to issue common stock were exercised or equity awards vest resulting in the issuance of common stock or conversion of notes into shares of the Company’s common stock that could increase the number of shares outstanding and lower the earnings per share of the Company’s common stock. This calculation is not done for periods in a loss position as this would be antidilutive. As of March 31, 2014, there were no stock options or stock awards that would have been included in the computation of diluted earnings per share that could potentially dilute basic earnings per share in the future.
The information related to basic and diluted earnings per share is as follows:
	Three Months Ended
	March 31,		March 31,
	2014		2013
Numerator:
Continuing operations:
Total Comprehensive Income (Loss)	$	-39,210	$	-30,643
Total	$	-39,210	$	-30,643
Total Comprehensive Income (Loss)	$	-39,210	$	-30,643
Denominator:
Weighted average number of shares outstanding – basic and diluted		23,350,793		23,134,813
EPS:
Basic:
Total Comprehensive Income (Loss)	$	-0.002	$	-0.001
Net Income (loss)	$	-0.002	$	-0.001
Diluted
Total Comprehensive Income (Loss)	$	-0.002	$	-0.001
Total Comprehensive Income (Loss)	$	-0.002	$	-0.001
Recent Accounting Updates
The Company does not expect the adoption of any other recently issued accounting pronouncements to have a significant impact on its results of operations, financial position or cash flow.

Interim_Financial_Statements

Interim Financial Statements	3 Months Ended
	Mar. 31, 2014
Quarterly Financial Information Disclosure [Abstract]	'
Interim Financial Statements	'
	Note 2. Interim Financial Statements
	The accompanying interim unaudited condensed financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In our opinion, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three month period ended March 31, 2014 are not necessarily indicative of the results that may be expected for the year ending December 31, 2014. For further information, refer to the financial statements and footnotes thereto included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2013.

Property_and_Equipment

Property and Equipment	3 Months Ended
	Mar. 31, 2014
Property, Plant and Equipment [Abstract]	'
Property and Equipment	'
	Note 3. Property and Equipment
	Property and equipment are stated at cost. Depreciation is calculated on the accelerated method over the estimated useful life of the assets. At March 31, 2014 and December 31, 2013, the major class of property and equipment were as follows:
		March 31,		December 31,		Estimated useful lives
		2014		2013
	Computer/Office Equipment	$	84,621	$	88,378	3-7 years
	Medical Equipment		601,774		601,774	3-7 years
	Leasehold Improvements		747,312		747,312	39 years
	Less: Accumulated Depreciation		-275,028		-237,763
	Net Book Value	$	1,158,679	$	1,199,701
	Depreciation expense was $39,820 and $39,436 for the three months ended March 31, 2014 and 2013, respectively.

Business_Combination

Business Combination	3 Months Ended
	Mar. 31, 2014
Business Combinations [Abstract]	'
Business Combination	'
	Note 4. Business Combination
	On December 10, 2012, the Company acquired 100% of Schuylkill Open MRI Inc. for consideration including cash which is described in detail below. Accordingly, the results of operations for SMI have been included in the accompanying consolidated financial statements from that date forward. SMI provides Magnetic Resonance Imaging (MRI) services. Pursuant to the terms of the Share Purchase Agreement, the Company paid an aggregate purchase price of $1,825,000 for the shares, plus a possible earn-out payment of up to $200,000 to be paid within sixty days after December 31, 2013 if certain post-closing revenue targets are met. This earn out payment is now due. The Company is exploring financing opportunities to pay the obligation.
	In connection with the Share Purchase Agreement, SMI entered into a lease agreement with one of the Sellers for the lease of two MRI machines. Under the terms of the lease, SMI is to make monthly payments of $11,013, plus applicable sales tax, over a period of 48 months. In addition, SMI agreed to make a one-time lease payment of $125,000 which was fully paid by March 30, 2013. The Company has guaranteed all of SMI’s obligations under the lease. At the end of the lease, SMI will have the option to purchase the MRI machines for a total purchase price of $1.00. The lease was accounted for as a capital lease for a total value of $555,000.
	Consideration for the acquisition comprised the following (at fair value):
	Cash	$	1,825,000
	Acquisition Liability		200,000
	Total consideration paid	$	2,025,000
	Following assets and liabilities were recognized in the acquisition (at fair value):
	Cash	$	42,887
	Accounts receivable		124,436
	Fixed Assets		1,345,647
	Deposits		8,140
	Non-compete agreement		27,917
	Goodwill		1,422,670
	Liabilities assumed		-946,697
	Net assets purchased	$	2,025,000
	The Company has evaluated this transaction and believes that the historical cost of the tangible and intangible assets acquired approximated fair market value given the current nature of the assets acquired. As part of the acquisition the Company has acquired Goodwill of $1,422,670. The Company expects to amortize the full amount of goodwill for tax purposes. At December 31, 2013 year end the Company performed an annual testing of goodwill for impairment, and valued the fair value of the reporting units to be greater than its carrying amount. As such, goodwill impairment was not recorded.
	The amounts of revenue included in the consolidated statement of operations for the three months ended March 31, 2014 and 2013 is $457,965, and $476,016, respectively.
	The amounts of gross earnings included in the consolidated statement of operations for three months ended March 31, 2014 and 2013 is $356,055, and $345,235, respectively.
	Costs related to the acquisition, which include legal fees, in the amount of $81,811 have been charged directly to operations and are included in legal and professional expenses in the 2012 consolidated statement of operations.

Goodwill

Goodwill	3 Months Ended
	Mar. 31, 2014
Goodwill and Intangible Assets Disclosure [Abstract]	'
Goodwill	'
	Note 5. Goodwill
	The change in the carrying amount of goodwill for the two years ended March 31, 2014 was:
	Balance as of January 1, 2013	$	-
	Acquisition of goodwill during the year		1,422,670
	Changes in goodwill during the year		-
	Balance as of December 31, 2013		1,422,670
	Changes in goodwill during the year		-
	Balance as of March 31, 2014	$	1,422,670

Lease_Commitments

Lease Commitments	3 Months Ended
	Mar. 31, 2014
Leases, Operating [Abstract]	'
Lease Commitments	'
	Note 6. Lease Commitments
	CTS has a lease commitment for its office space of approximately $2,450 minimum rental, and approximately $2,850 in utilities, realty taxes, and operating costs, for a total of approximately $5,300 per month. The Lease renewed in April 2013 for a period of five years and will expire in March 2018. On renewal, CTS was given a rental credit of approximately $28,000. This lease was accounted for as an operating lease.
	CTS has a lease for its off-site servers at a cost of approximately $1,500 per month. This lease is accounted for as an operating lease. The lease will expire in April 30, 2017.
	SMI has a lease for its off-site servers at a cost of approximately $1,092 per month. This lease is accounted for as an operating lease on a month-to-month basis.
	SMI entered into a lease commitment for its office space in Pottsville, Pennsylvania. The lease will expire on June 30, 2016, and it is renewable for an additional term of 5 years on the same terms and conditions. Monthly rental amounts in 2014 were $5,437 per month plus approximately $1,674 in utilities, realty taxes, and operating costs.
	SMI has a lease for office space in Dallas, Texas of approximately $880 per month plus approximately $660 in utilities, realty taxes, and operating costs. The lease will expire in August 31, 2014.
	Expected Lease commitments for the next three years:
	Year	Office Space		Servers		Total
	2014	$	117,859	$	23,328	$	141,187
	2015		148,932		31,104		180,036
	2016		106,266		31,104		137,370
		$	373,057	$	85,536	$	458,593

Accounts_Payable_and_Accrued_L

Accounts Payable and Accrued Liabilities	3 Months Ended
	Mar. 31, 2014
Payables and Accruals [Abstract]	'
Accounts Payable and Accrued Liabilities	'
	Note 7. Accounts Payable and Accrued Liabilities
	As of March 31, 2013 and December 31, 2013, the trade payables and accrued liabilities of the Company were $539,910 and $608,151, respectively. Of the total amount as of March 31, 2014, approximately $231,097 is related to CTS operations and $278,443 is related to SMI operations. The balance of the accounts is for vendors supplying goods and services used in the normal course of business. Of the total amount as of December 31, 2013, approximately $301,965 is related to CTS operations and $278,854 is related to SMI operations. The balance of the accounts is for vendors supplying goods and services used in the normal course of business.

Obligations_Under_Capital_Leas

Obligations Under Capital Lease	3 Months Ended
	Mar. 31, 2014
Leases, Capital [Abstract]	'
Obligations Under Capital Lease	'
	Note 8. Obligations Under Capital Lease
	On December 10, 2012, the Company entered into a lease agreement with one of the sellers of SMI to lease the two MRI machines. Under the terms of the lease, SMI is to make monthly payments of $11,013, plus applicable sales tax, over a period of 48 months. In addition, SMI agreed to make a one-time lease payment of $125,000, which was paid by March 30, 2013. The Company has guaranteed all of SMI’s obligations under the lease. At the end of the lease, SMI will have the option to purchase the MRI machines for a total purchase price of $1.00. The lease was accounted for as a capital lease for a total value of $555,000.
	Minimum future lease payments under the capital lease are as follows as of March 31, 2014:
	2014		99,115
	2015		132,152
	2016		132,150
	Total minimum lease payments		363,417
	Less amount representing interest		49,012
	Present value of minimum lease payments		314,405
	Less current portion of minimum lease payments		104,009
	Long-term capital lease obligations	$	210,396
	The gross amount of the equipment held under capital leases totals $555,000 ($407,083 net book value after accumulated amortization of $147,917) at March 31, 2014.
	Amortization of the capital lease assets is included in the depreciation expense of $27,750 for the three months ending March 31, 2014.

Promissory_Notes

Promissory Notes	3 Months Ended
	Mar. 31, 2014
Other Liabilities Disclosure [Abstract]	'
Promissory Notes	'
	Note 9. Promissory Notes
	During the year ended December 31, 2013, $6,616 in accrued interest was recorded on the notes, and $87,225 was paid towards the balance of the notes.$18,736 of the notes assumed on acquisition represented by a promissory note accruing interest at an annual rate of 10.5% and paid out monthly. $45,792 of the notes assumed on acquisition represented by a promissory note accruing interest at an annual rate of 6% and paid out monthly.
	During the three months ended March 31, 2014, $593 in accrued interest was recorded on the notes, and $13,110 was paid towards the balance of the notes.
	A summary of the promissory notes is as follows:
	Promissory notes at January 1, 2013	$	119,624
	Added: Proceeds through December 31, 2013		6,000
	Added: Accrued Interest through December 31, 2013		6,616
	Less: Payments through December 31, 2013		-87,225
	Promissory notes at December 31, 2013	$	45,015
	Added: Accrued Interest through March 31, 2014		593
	Less: Payments through March 31, 2014		-13,110
	Promissory notes at March 31, 2014	$	32,498
	Less: Short term portion		18,669
	Long term portion March 31, 2014	$	13,829

Convertible_Notes

Convertible Notes	3 Months Ended
	Mar. 31, 2014
Debt Disclosure [Abstract]	'
Convertible Notes	'
	Note 10. Convertible Notes
	Series B:
	On December 3, 2012, the Company sold, through a private placement to accredited investors, three year 12% convertible notes (“Series B Notes”) in the aggregate principal amount of $1,865,000. On March 27, 2013 the company sold an additional $150,000 of Series B Notes.
	Series B Notes pay interest at a rate of 12% per annum, payable to the holder at 1% per month. The Notes are convertible into common shares of the Company at $0.10 per share. In addition, each holder of Series B Notes received shares dependent on the dollar amount of Notes purchased. The total number of shares issued was 5,315,000 shares of common stock of the Company. $1,865,000 of Series B Notes issued on December 3, 2012 mature on December 31, 2013; and $150,000 of Series B Notes issued March 27, 2013 mature on March 31, 2016.
	For the three month ended March 31, 2014, $60,450 in accrued interest was recorded on the notes and paid.
	In accordance with ASC 470 on issuance of the shares given, the Company recognized additional paid-in capital and a discount against the notes for a total of $244,275. Amortization of the discount for the three months ended March 31, 2014 was $20,356.
	The Details of Series B Notes are as follows:
	Issuance		December 31,			December 31,		Three Months		Three Months		Three Months		Three Months		March 31,		Maturity
	Date		2013			2013		Ended		Ended		Ended		Ended		2014		Date
			Balance			Unamortized		March 31,		March 31,		March 31,		March 31,		Balance, net
						Discount		2014		2014		2014		2014
						Beginning		Proceeds		Accrued		(Payments)		Amortization
						Balance				Interest				of Debt
														Discount
	3-Dec-12		$	25,000		$	-719	$	-	$	750	$	-750	$	94	$	24,375	31-Dec-15
	3-Dec-12			125,000			-10,569		-		3,750		-3,750		1,244		115,675	31-Dec-15
	3-Dec-12			50,000			-2,156		-		1,500		-1,500		281		48,125	31-Dec-15
	3-Dec-12			25,000			-719		-		750		-750		94		24,375	31-Dec-15
	3-Dec-12			25,000			-719		-		750		-750		94		24,375	31-Dec-15
	3-Dec-12			25,000			-719		-		750		-750		94		24,375	31-Dec-15
	3-Dec-12			1,500,000			-129,375		-		45,000		-45,000		16,875		1,387,500	31-Dec-15
	3-Dec-12			50,000			-2,156		-		1,500		-1,500		281		48,125	31-Dec-15
	3-Dec-12			15,000			-431		-		450		-450		56		14,625	31-Dec-15
	3-Dec-12			100,000			-7,081		-		3,000		-3,000		856		93,775	31-Dec-15
	27-Mar-13			25,000			-1,162		-		750		-750		129		23,967	31-Mar-16
	27-Mar-13			25,000			-1,162		-		750		-750		129		23,967	31-Mar-16
	27-Mar-13			25,000			-1,162		-		750		-750		129		23,967	31-Mar-16
	Total		$	2,015,000		$	-158,131	$	-	$	60,450	$	-60,450	$	20,356	$	1,877,,225
	Summary of Series B Notes is as follows:
		March 31,			December 31,
		2014			2013
	Convertible notes Beginning Balance	$	2,015,000		$	2,015,000
	Less: unamortized debt discount		-137,775			-158,131
	Convertible notes principal, net		1,877,225			1,856,869
	Less: Payments in Period		-60,450			-235,300
	Added: Accrued interest		60,450			235,300
	Total Convertible notes, net	$	1,877,225		$	1,856,869
	Less: Short term portion, net		-			-
	Long term portion, net	$	1,877,225		$	1,856,869
	Following are maturities of the long –term debt in Series B Notes for each of the next 5 years:
			Principal			Interest		Amortization
			Payments			Payments		of Discount
	2014		$	-		$	181,350	$	61,069
	2015			1,865,000			241,800		75,156
	2016			150,000			4,500		1,550
	2017			-			-		-
	2018			-			-		-
	Total		$	2,015,000		$	427,650	$	137,775
	Individually issued Convertible Note
	On March 26, 2014 the Company issued $300,000 in convertible note to a non-affiliate. The note pays interest at a rate of 12% per annum, payable to the holder at 1% per month. In addition to interest payments the Company will be making monthly payments of $5,000 towards the principal balance beginning June 1, 2014 for three years until the note due date of February 27, 2017. The note is convertible into common shares of the Company at $0.15 per share. In addition, the non-affiliate will receive 300,000 shares as part of the note agreement.
	For the three month ended March 31, 2014, $789 in accrued interest was recorded on the notes, and was paid on May 1, 2014.
	In accordance with ASC 470 on issuance of the bonus shares given, the Company recognized additional paid-in capital and a discount against the notes for a total of $25,500.
	Summary of the notes is as follows:
		March 31,			December 31,
		2014			2013
	Convertible note Beginning Balance	$	300,000		$	-
	Less: unamortized debt discount		-25,500			-
	Convertible notes principal, net		274,500			-
	Less: Payments in Period		-			-
	Added: Accrued interest		789			-
	Total Convertible note, net	$	275,289		$	-
	Less: short term portion, net		54,900			-
	Long term portion, net	$	220,389		$	-
Following are maturity of the individually issued convertible note for each of the next 5 years:
		Principal			Interest		Amortization
		Payments			Payments		of Discount
2014		$	35,000		$	23,803	$	6,375
2015			60,000			28,496		8,500
2016			60,000			21,360		8,500
2017			145,000			4,103		2,125
2018			-			-		-
Total		$	300,000		$	77,762	$	25,500

Related_Party_Transactions

Related Party Transactions	3 Months Ended
	Mar. 31, 2014
Related Party Transactions [Abstract]	'
Related Party Transactions	'
	Note 11. Related Party Transactions
	During the year ended December 31, 2013, Richard Jagodnik (an officer and shareholder of the Company), had a $7,062 note payable from DIIC. The note was non-interest bearing and payable on demand. As at December 31, 2013 the note is fully paid.
	During the second quarter of 2010, Richard Jagodnik loaned DIIC $42,944 under the same terms of convertible notes Series A as described in Note 9 above. The note was carried in Canadian dollars and a foreign exchange gain of $693 was recorded for the year ended December 31, 2013. For the year ended December 31, 2013 $48 in accrued interest was recorded and added to the note. As at December 31, 2013 the note was fully paid.
	For the three months ended March 31, 2014 the company did not have any related party debt outstanding.
	Summary of related party notes is as follows:
		Shareholder		Shareholder
		Note		Convertible Note
	Balance at December 31, 2012	$	7,062	$	10,936
	Added: Accrued Interest		-		48
	Less: Foreign Exchange Gain		-		693
	Less: Payments		-7,062		-10,291
	Balance at December 31, 2013	$	-	$	-
	Balance at March 31, 2014	$	-	$	-

Major_Customers

Major Customers	3 Months Ended
	Mar. 31, 2014
Major Customers	'
Major Customers	'
	Note 12. Major Customers
	For the three months ending March 30, 2014 and 2013, revenue was derived primarily from radiology services.
	Major customers representing more than 10% of total revenue for the three months ended March 31, 2014 and 2013 are as follow:
		Three Months Ended			Three Months Ended
		31-Mar-14			31-Mar-13
	Customers	Revenue		Revenue	Revenue		Revenue
		amount		percentage	amount		percentage
	Contract A	$	260,873	22%	$	281,675	22%
	Contract E		205,727	17%		293,092	23%
	Contract F		132,972	11%		138,625	11%
	Contract H	$	74,408	6%	$	62,899	5%
	Closing balances of accounts receivable for our major customers were as follow:
		Balance at			Balance at
		31-Mar-14			31-Dec-13
		Accounts		Accounts	Accounts		Accounts
		Receivable		Receivable	Receivable		Receivable
	Customers	Closing Balance		Percentage	Closing Balance		Percentage
	Contract A	$	18,914	6%	$	17,876	6%
	Contract E		51,614	17%		95,552	34%
	Contract F		44,176	15%		46,796	17%
	Contract G		13,034	4%		12,382	4%
	Contract H	$	25,097	8%	$	54,757	19%

Major_Vendors

Major Vendors	3 Months Ended
	Mar. 31, 2014
Major Vendors	'
Major Vendors	'
	Note 13. Major Vendors
	The company has one major vendor providing its system software and support. Expenses relating to this vendor for the three months ended March 31, 2014 and 2013 were $13,455 and $15,165, respectively.

Common_Stock_Transactions

Common Stock Transactions	3 Months Ended
	Mar. 31, 2014
Equity [Abstract]	'
Common Stock Transactions	'
	Note 14. Common Stock Transactions
	For the three months ended March 31, 2014, 5,000 shares were issued for services valued at $150 based upon the closing price of our common stock at the grant date.
	For the three months ended March 31, 2014, 300,000 shares were issued as part of convertible notes agreements. The shares were valued at $25,500 based upon the closing price of our common stock at the grant date.
	For the year ended December 31, 2013, 300,000 shares were issued as part of convertible notes agreements. The shares were valued at $18,600 based upon the closing price of our common stock at the grant date.
	For the year ended December 31, 2012 5,015,000 shares were issued as an additional part of convertible notes agreements. The shares were valued at $225,675 based upon the closing price of our common stock at the grant date.

Income_Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2014
Income Tax Disclosure [Abstract]	'
Income Taxes	'
	Note 15. Income Tax
	The Company follows ASC 740, Income Taxes, which requires the recognition of deferred tax liabilities and assets for the expected future tax consequences of events that have been included in the consolidated financial statements or tax returns. Under this method, deferred tax liabilities and assets are determined based on the difference between consolidated financial statements and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse.
	The provisions of ASC 740 require companies to recognize in their financial statements the impact of a tax position if that position is more likely than not to be sustained upon audit, based upon the technical merits of the position. ASC 740 prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken on a tax return. ASC 740 also provides guidance on de-recognition, classification, interest and penalties, accounting in interim periods and disclosure.
	Management does not believe that the Company has any material uncertain tax positions requiring recognition or measurement in accordance with the provisions of ASC 740. Accordingly, the adoption of these provisions of ASC 740 did not have a material effect on the Company’s financial statements. The Company’s policy is to record interest and penalties on uncertain tax positions, if any, as income tax expense.

Going_Concern

Going Concern	3 Months Ended
	Mar. 31, 2014
Going Concern	'
Going Concern	'
	Note. 16. Going Concern
	As shown in the accompanying consolidated financial statements, the company incurred net losses of $39,210 for the three months ended March 31, 2014 as well as a working capital deficit of $289,774. These conditions raise substantial doubt as to if the company’s ability to continue as a going concern. Management plan to raise additional financing in order to continue its operations and fulfil its debt obligations in 2015, but there can be no assurances that the plan will be successful. These consolidated financial statements do not include any adjustments that might be necessary if the company is unable to continue as a going concern.

Subsequent_Events

Subsequent Events	3 Months Ended
	Mar. 31, 2014
Subsequent Events [Abstract]	'
Subsequent Events	'
	Note 17. Subsequent events
	Subsequent to quarter end, the company issued $75,000 in convertible notes to non-affiliates.
	Subsequent to quarter end, the company’s wholly –owned subsidiary, CTS, received noticed that one of its major customers is terminating its contract with CTS. The client is known as contract “A” as shown in Note 12 above.
	The Company evaluated subsequent events through the date the consolidated financial statements were issued.

Accounting_Policies_Policies

Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2014
Accounting Policies [Abstract]	'
Organization and Basis of Presentation	'
	Organization and Basis of Presentation
	Diagnostic Imaging International Corp., (“DIIC” or the “Company”) a Nevada Corporation, was incorporated in 2000. In 2005, the Company developed a business plan for private healthcare opportunities in Canada with the objective of owning and operating private diagnostic imaging clinics. In 2009, the Company purchased Custom Teleradiology Services, Inc. (“CTS”), a company that provides remote reading of diagnostic imaging scans for rural hospitals and clinics. In early 2010, the Company modified its business plan to grow its CTS subsidiary while commencing the acquisition of existing full service imaging clinics located in the United States and exploring the development of new diagnostic imaging technology. In 2012, the Company purchased Schuylkill Medical Imaging (“SMI”) an independent Magnetic Resonance Imaging (MRI) facility located in Pottsville, Pennsylvania.
	Basis of Presentation
	These consolidated financial statements and related notes are presented in accordance with accounting principles generally accepted in the United States, and are expressed in U.S. dollars. The Company’s fiscal year-end is December 31.
Principle of Consolidation	'
	Principle of Consolidation
	The consolidated financial statements include the accounts of Diagnostic Imaging International, Corp., and our wholly-owned subsidiaries, Canadian Teleradiology Services, Inc. and Schuylkill Open MRI, Inc. Intercompany accounts and transactions have been eliminated in the consolidated financial statements. CTS’ and SMI’s accumulated earnings prior to their acquisition (March 2, 2009 and December 10, 2012, respectively) are not included in the consolidated balance sheet.
Reclassification of Accounts	'
	Reclassification of Accounts
	Certain prior period amounts have been reclassified to conform to the March 31, 2014 presentation.
Use of Estimates and Assumptions	'
	Use of Estimates and Assumptions
	The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States (“GAAP”) requires management to make estimates and assumptions that affect (i) the reported amounts of assets and liabilities, (ii) the disclosure of contingent assets and liabilities known to exist as of the date the consolidated financial statements are published, and (iii) the reported amount of net sales, expenses and costs recognized during the periods presented. Adjustments made with respect to the use of estimates often relate to improved information not previously available. Uncertainties with respect to such estimates and assumptions are inherent in the preparation of consolidated financial statements; accordingly, actual results could differ from these estimates.
Cash and Cash Equivalents	'
	Cash and Cash Equivalents
	The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. At March 31, 2014, and December 31, 2013, cash includes cash on hand and cash in the bank.
Accounts Receivable Credit Risk	'
	Accounts Receivable Credit Risk
	The allowance for doubtful accounts is maintained at a level sufficient to provide for estimated credit losses based on evaluating known and inherent risks in the receivables portfolio.
	Management evaluates various factors including expected losses and economic conditions to predict the estimated realization on outstanding receivables.
Goodwill and Indefinite Intangible Assets	'
	Goodwill and Indefinite Intangible Assets
	The Company follows the provisions of Financial Accounting Standard (“FASB”) Accounting Standards Codification (“ASC”) Topic 350, Goodwill and Other Intangible Assets. In accordance with ASC Topic 350, goodwill, representing the excess of the purchase price and related costs over the value assigned to net tangible and identifiable intangible assets of businesses acquired and accounted for under the purchase method, acquired in business combinations is assigned to reporting units that are expected to benefit from the synergies of the combination as of the acquisition date. Under this standard, goodwill and intangibles with indefinite useful lives are not amortized. The Company assesses goodwill and indefinite-lived intangible assets for impairment annually during the fourth quarter, or more frequently if events and circumstances indicate impairment may have occurred in accordance with ASC Topic 350. If the carrying value of a reporting unit's goodwill exceeds its implied fair value, the Company records an impairment loss equal to the difference. ASC Topic 350 also requires that the fair value of indefinite-lived purchased intangible assets be estimated and compared to the carrying value. The Company recognizes an impairment loss when the estimated fair value of the indefinite-lived purchased intangible assets is less than the carrying value. If the implied fair value of goodwill is lower than its carrying amount, goodwill impairment is indicated and goodwill is written down to its implied fair value. Subsequent increases in goodwill value are not recognized in the consolidated financial statements.
Intangible Assets	'
	Intangible Assets
	CTS has contracts with various hospitals in the province of Ontario, Canada. These contracts are for specific radiology services to be provided for a length of time. Contracts varied between one and five years. The contracts do not specify any minimum billings for any period of time. The contracts in existence on acquisition were valued on acquisition using a discounted cash flow model and the fair value as recorded is amortized over the remaining life of the contract using the straight line method.
Revenue Recognition	'
	Revenue Recognition
	The Company holds contracts with several hospitals and groups of health care facilities to provide Teleradiology services for a specific period of time. The Company bills for services rendered on a monthly basis. As described above, in accordance with the requirement of Staff Accounting Bulletin (“SAB”) 104, the Company recognizes revenue when: (1) persuasive evidence of an arrangement exists (contracts); (2) delivery has occurred (monthly); (3) the seller’s price is fixed or determinable (per the customer’s contract, and services performed); and (4) collectability is reasonably assured (based upon our credit policy).
	Revenue is accounted for under the guidelines established by SAB 101, Revenue Recognition in Financial Statements, and ASC Topic 605-45, Revenue Recognition – Principal Agent Considerations. For CTS, the Company has the following indicators of gross revenue reporting: (1) CTS is the primary obligator in the provision of services to the Hospitals under contract, (2) CTS has latitude in establishing price, and negotiating contracts with each hospital, (3) CTS negotiates and determines the service specification to be provided to each hospital client, (4) CTS has complete discretion in supplier selection, and (5) CTS has the credit risk. Accordingly, the Company records CTS revenue at gross.
	For SMI, revenue is recorded at the time of service.
Cost of Sales	'
	Cost of Sales
	Cost of sales includes fees paid to radiologists for teleradiology services, transcription fees, equipment repairs, system license and usage costs.
Impairment of Long-Lived Assets	'
	Impairment of Long-Lived Assets
	In accordance with ASC Topic 360, Property, Plant and Equipment, property, plant, and equipment, and purchased intangibles are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Goodwill and other intangible assets are tested for impairment. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset.
Amortization and Depreciation	'
	Amortization and Depreciation
	Depreciation and amortization are calculated using the straight-line method over the useful lives.
Stock Based Compensation	'
	Stock Based Compensation
	The Company measures all share-based payments to employees (which includes non-employee Board of Directors), including employee stock options, warrants and restricted stock, at the fair value of the award and expenses it over the requisite service period (generally the vesting period). The fair value of common stock options or warrants granted to employees is estimated at the date of grant using the Black-Scholes option pricing model. The calculation also takes into account the common stock fair market value at the grant date, the exercise price, the expected life of the common stock option or warrant, the dividend yield and the risk-free interest rate.
	The Company from time to time may issue stock options, warrants and restricted stock to acquire goods or services from third parties. Restricted stock, options or warrants issued to other than employees or directors are recorded on the basis of their fair value. The options or warrants are valued using the Black-Scholes option pricing model on the basis of the market price of the underlying equity instrument on the “valuation date,” which for options and warrants related to contracts that have substantial disincentives to non-performance, is the date of the contract, and for all other contracts is the vesting date. Expenses related to the options and warrants are recognized on a straight-line basis over the period which services are to be received.
Fair Value of Financial Instruments	'
	Fair Value of Financial Instruments
	The fair value of a financial instrument is the amount at which the instrument could be exchanged in a current transaction between willing parties other than in a forced sale or liquidation.
	The carrying amounts of the Company’s financial instruments, including cash, accounts receivable, accounts payable and accrued liabilities and income taxes payable approximate fair value due to their most maturities.
Fair Value Measurements	'
	Fair Value Measurements
	The Company follows paragraph 825-10-50-10 of the FASB Accounting Standards Codification (“ASC”) for disclosures about fair value of its financial instruments and paragraph 820-10-35-37 of the FASB ASC (“Paragraph 820-10-35-37”) to measure the fair value of its financial instruments. Paragraph 820-10-35-37 establishes a framework for measuring fair value in U.S. GAAP, and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, Paragraph 820-10-35-37 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The three levels of fair value hierarchy defined by Paragraph 820-10-35-37 are described below:
	Level 1 Quoted market prices available in active markets for identical assets or liabilities as of the reporting date.
	Level 2 Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date.
	Level 3 Pricing inputs that are generally observable inputs and not corroborated by market data.
	The carrying amounts of the Company’s financial assets and liabilities, such as cash and accounts payable approximate their fair values because of the short maturity of these instruments.
	The company does not have assets and liabilities that are carried at fair value on a recurring basis.
	The Company’s functional currency for its wholly-owned subsidiary, CTS, is the Canadian dollar, and their financial statements have been translated into U.S. dollars. The Canadian dollar based accounts of the Company’s foreign operations have been translated into United States dollars using the current rate method. Assets and liabilities of those operations are translated into U.S. dollars using exchange rates as of the balance sheet date; income and expenses are translated using the weighted average exchange rates for the reporting period. Translation adjustments are recorded as accumulated other comprehensive income (loss), a separate component of stockholders’ equity.
Income Taxes	'
	Income Taxes
	The Company accounts for income taxes in accordance with ASC Topic 740, Income Taxes. This statement prescribes the use of the asset and liability method whereby deferred tax asset and liability account balances are determined based on differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse.
Net Income/ (Loss) Per Share	'
	Net Income (Loss) Per Share
	The Company follows the provisions of ASC Topic 260, Earnings per Share. Basic net income (loss) per share is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding during the period. Basic and diluted losses per share are the same as all potentially dilutive securities are anti-dilutive.
	Basic earnings per share is computed by dividing net income available to common shareholders by the weighted average number of common shares outstanding during the period. Diluted earnings per share reflects the potential dilution that could occur if stock options and other commitments to issue common stock were exercised or equity awards vest resulting in the issuance of common stock or conversion of notes into shares of the Company’s common stock that could increase the number of shares outstanding and lower the earnings per share of the Company’s common stock. This calculation is not done for periods in a loss position as this would be antidilutive.
Recent Accounting Updates	'
	Recent Accounting Updates
	The Company does not expect the adoption of any other recently issued accounting pronouncements to have a significant impact on its results of operations, financial position or cash flow.

Organization_and_Summary_of_Si1

Organization and Summary of Significant Accounting Policies (Tables)	3 Months Ended
	Mar. 31, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Schedule of Earnings Per Share	'
		Three Months Ended
		March 31,		March 31,
		2014		2013
	Numerator:
	Continuing operations:
	Total Comprehensive Income (Loss)	$	-39,210	$	-30,643
	Total	$	-39,210	$	-30,643
	Total Comprehensive Income (Loss)	$	-39,210	$	-30,643
	Denominator:
	Weighted average number of shares outstanding – basic and diluted		23,350,793		23,134,813
	EPS:
	Basic:
	Total Comprehensive Income (Loss)	$	-0.002	$	-0.001
	Net Income (loss)	$	-0.002	$	-0.001
	Diluted
	Total Comprehensive Income (Loss)	$	-0.002	$	-0.001
	Total Comprehensive Income (Loss)	$	-0.002	$	-0.001

Property_and_Equipment_Tables

Property and Equipment (Tables)	3 Months Ended
	Mar. 31, 2014
Property, Plant and Equipment [Abstract]	'
Property Plant and Equipment	'
		March 31,		December 31,		Estimated useful lives
		2014		2013
	Computer/Office Equipment	$	84,621	$	88,378	3-7 years
	Medical Equipment		601,774		601,774	3-7 years
	Leasehold Improvements		747,312		747,312	39 years
	Less: Accumulated Depreciation		-275,028		-237,763
	Net Book Value	$	1,158,679	$	1,199,701

Business_Combination_Tables

Business Combination (Tables)	3 Months Ended
	Mar. 31, 2014
Business Combinations [Abstract]	'
Schedule of Purchase Price Allocation	'
	Cash	$	1,825,000
	Acquisition Liability		200,000
	Total consideration paid	$	2,025,000
Schedule of Recognized Assets Acquired and Liabilities Assumed	'
	Cash	$	42,887
	Accounts receivable		124,436
	Fixed Assets		1,345,647
	Deposits		8,140
	Non-compete agreement		27,917
	Goodwill		1,422,670
	Liabilities assumed		-946,697
	Net assets purchased	$	2,025,000

Goodwill_Tables

Goodwill (Tables)	3 Months Ended
	Mar. 31, 2014
Goodwill and Intangible Assets Disclosure [Abstract]	'
Schedule of Goodwill	'
	Balance as of January 1, 2013	$	-
	Acquisition of goodwill during the year		1,422,670
	Changes in goodwill during the year		-
	Balance as of December 31, 2013		1,422,670
	Changes in goodwill during the year		-
	Balance as of March 31, 2014	$	1,422,670

Lease_Commitments_Tables

Lease Commitments (Tables)	3 Months Ended
	Mar. 31, 2014
Leases, Operating [Abstract]	'
Schedule of Lease Commitments	'
	Year	Office Space		Servers		Total
	2014	$	117,859	$	23,328	$	141,187
	2015		148,932		31,104		180,036
	2016		106,266		31,104		137,370
		$	373,057	$	85,536	$	458,593

Obligations_Under_Capital_Leas1

Obligations Under Capital Lease (Tables)	3 Months Ended
	Mar. 31, 2014
Leases, Capital [Abstract]	'
Schedule of Future Minimum Lease Payments for Capital Leases	'
	2014		99,115
	2015		132,152
	2016		132,150
	Total minimum lease payments		363,417
	Less amount representing interest		49,012
	Present value of minimum lease payments		314,405
	Less current portion of minimum lease payments		104,009
	Long-term capital lease obligations	$	210,396

Promissory_Notes_Tables

Promissory Notes (Tables)	3 Months Ended
	Mar. 31, 2014
Other Liabilities Disclosure [Abstract]	'
Schedule of Promissory Notes	'
	Promissory notes at January 1, 2013	$	119,624
	Added: Proceeds through December 31, 2013		6,000
	Added: Accrued Interest through December 31, 2013		6,616
	Less: Payments through December 31, 2013		-87,225
	Promissory notes at December 31, 2013	$	45,015
	Added: Accrued Interest through March 31, 2014		593
	Less: Payments through March 31, 2014		-13,110
	Promissory notes at March 31, 2014	$	32,498
	Less: Short term portion		18,669
	Long term portion March 31, 2014	$	13,829

Convertible_Notes_Tables

Convertible Notes (Tables)	3 Months Ended
	Mar. 31, 2014
Debt Disclosure [Abstract]	'
Schedule of Debt	'
	The Details of Series B Notes are as follows:
	Issuance		December 31,			December 31,		Three Months		Three Months		Three Months		Three Months		March 31,		Maturity
	Date		2013			2013		Ended		Ended		Ended		Ended		2014		Date
			Balance			Unamortized		March 31,		March 31,		March 31,		March 31,		Balance, net
						Discount		2014		2014		2014		2014
						Beginning		Proceeds		Accrued		(Payments)		Amortization
						Balance				Interest				of Debt
														Discount
	3-Dec-12		$	25,000		$	-719	$	-	$	750	$	-750	$	94	$	24,375	31-Dec-15
	3-Dec-12			125,000			-10,569		-		3,750		-3,750		1,244		115,675	31-Dec-15
	3-Dec-12			50,000			-2,156		-		1,500		-1,500		281		48,125	31-Dec-15
	3-Dec-12			25,000			-719		-		750		-750		94		24,375	31-Dec-15
	3-Dec-12			25,000			-719		-		750		-750		94		24,375	31-Dec-15
	3-Dec-12			25,000			-719		-		750		-750		94		24,375	31-Dec-15
	3-Dec-12			1,500,000			-129,375		-		45,000		-45,000		16,875		1,387,500	31-Dec-15
	3-Dec-12			50,000			-2,156		-		1,500		-1,500		281		48,125	31-Dec-15
	3-Dec-12			15,000			-431		-		450		-450		56		14,625	31-Dec-15
	3-Dec-12			100,000			-7,081		-		3,000		-3,000		856		93,775	31-Dec-15
	27-Mar-13			25,000			-1,162		-		750		-750		129		23,967	31-Mar-16
	27-Mar-13			25,000			-1,162		-		750		-750		129		23,967	31-Mar-16
	27-Mar-13			25,000			-1,162		-		750		-750		129		23,967	31-Mar-16
	Total		$	2,015,000		$	-158,131	$	-	$	60,450	$	-60,450	$	20,356	$	1,877,,225
Schedule of Debt Conversions	'
	Summary of Series B Notes is as follows:
		March 31,			December 31,
		2014			2013
	Convertible notes Beginning Balance	$	2,015,000		$	2,015,000
	Less: unamortized debt discount		-137,775			-158,131
	Convertible notes principal, net		1,877,225			1,856,869
	Less: Payments in Period		-60,450			-235,300
	Added: Accrued interest		60,450			235,300
	Total Convertible notes, net	$	1,877,225		$	1,856,869
	Less: Short term portion, net		-			-
	Long term portion, net	$	1,877,225		$	1,856,869
	Summary of Individually issued Convertible Note
		March 31,			December 31,
		2014			2013
	Convertible note Beginning Balance	$	300,000		$	-
	Less: unamortized debt discount		-25,500			-
	Convertible notes principal, net		274,500			-
	Less: Payments in Period		-			-
	Added: Accrued interest		789			-
	Total Convertible note, net	$	275,289		$	-
	Less: short term portion, net		54,900			-
	Long term portion, net	$	220,389		$	-
Schedule of Maturities of Long Term Debt	'
	Following are maturities of the long –term debt in Series B Notes for each of the next 5 years:
			Principal			Interest		Amortization
			Payments			Payments		of Discount
	2014		$	-		$	181,350	$	61,069
	2015			1,865,000			241,800		75,156
	2016			150,000			4,500		1,550
	2017			-			-		-
	2018			-			-		-
	Total		$	2,015,000		$	427,650	$	137,775
	Following are maturities of Individually issued Convertible Note for each of the next 5 years:
			Principal			Interest		Amortization
			Payments			Payments		of Discount
	2014		$	35,000		$	23,803	$	6,375
	2015			60,000			28,496		8,500
	2016			60,000			21,360		8,500
	2017			145,000			4,103		2,125
	2018			-			-		-
	Total		$	300,000		$	77,762	$	25,500

Related_Party_Transaction_Tabl

Related Party Transaction (Tables)	3 Months Ended
	Mar. 31, 2014
Related Party Transactions [Abstract]	'
Schedule of Related Party Transactions	'
		Shareholder		Shareholder
		Note		Convertible Note
	Balance at December 31, 2012	$	7,062	$	10,936
	Added: Accrued Interest		-		48
	Less: Foreign Exchange Gain		-		693
	Less: Payments		-7,062		-10,291
	Balance at December 31, 2013	$	-	$	-
	Balance at March 31, 2014	$	-	$	-

Major_Customers_Tables

Major Customers (Tables)	3 Months Ended
	Mar. 31, 2014
Major Customers	'
Schedule of Revenue by Major Customers	'
		Three Months Ended			Three Months Ended
		31-Mar-14			31-Mar-13
	Customers	Revenue		Revenue	Revenue		Revenue
		amount		percentage	amount		percentage
	Contract A	$	260,873	22%	$	281,675	22%
	Contract E		205,727	17%		293,092	23%
	Contract F		132,972	11%		138,625	11%
	Contract H	$	74,408	6%	$	62,899	5%
Schedule of Accounts Receivable by Major Customers	'
		Balance at			Balance at
		31-Mar-14			31-Dec-13
		Accounts		Accounts	Accounts		Accounts
		Receivable		Receivable	Receivable		Receivable
	Customers	Closing Balance		Percentage	Closing Balance		Percentage
	Contract A	$	18,914	6%	$	17,876	6%
	Contract E		51,614	17%		95,552	34%
	Contract F		44,176	15%		46,796	17%
	Contract G		13,034	4%		12,382	4%
	Contract H	$	25,097	8%	$	54,757	19%

Organization_and_Summary_of_Si2

Organization and Summary of Significant Accounting Policies (Details 1) (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Numerator	'	'
Total comprehensive income (loss)	($39,210)	($30,643)
Denominator	'	'
Weighted average number of shares outstanding - basic and diluted	23,350,793	23,134,813
Earnings per Share	'	'
Basic earnings per share from total comprehensive income (loss)	($0.00)	($0.00)
Diluted earnings per share from total comprehensive income (loss)	($0.00)	($0.00)

Organization_and_Summary_of_Si3

Organization and Summary of Significant Accounting Policies (Details Narrative) (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Dec. 31, 2013
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'	'	'
Allowance for bad debts	$24,816	'	$17,294
Accounts receivable, concentration risk	40.00%	70.00%	'

Property_and_Equipment_Details

Property and Equipment (Details) (USD $)	3 Months Ended
	Mar. 31, 2014	Dec. 31, 2013
Property Plant And Equipment [Line Items]	'	'
Property and equipment, accumulated depreciation	($275,028)	($237,763)
Computer/Office Equipment	'	'
Property Plant And Equipment [Line Items]	'	'
Property and equipment, gross	84,621	88,378
Property and equipment, estimated useful lives	'3-7 years	'
Medical Equipment	'	'
Property Plant And Equipment [Line Items]	'	'
Property and equipment, gross	601,774	601,774
Property and equipment, estimated useful lives	'3-7 years	'
Leasehold Improvements	'	'
Property Plant And Equipment [Line Items]	'	'
Property and equipment, gross	$747,312	$747,312
Property and equipment, estimated useful lives	'39 years	'

Property_and_Equipment_Details1

Property and Equipment (Details Narrative) (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Property, Plant and Equipment [Abstract]	'	'
Property and equipment, depreciation expense	$39,820	$39,436

Business_Combination_Details_1

Business Combination (Details 1) (USD $)	12 Months Ended
	Dec. 31, 2012
Business Combination, Consideration Transferred	'
Cash consideration paid	$1,825,000
Acquisition Liability	200,000
Total consideration paid	$2,025,000

Business_Combination_Details_2

Business Combination (Details 2) (USD $)	Mar. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Business Combinations [Abstract]	'	'	'
Fair value of cash acquired	'	'	$42,887
Fair value accounts receivable acquired	'	'	124,436
Fair value fixed assets acquired	'	'	1,345,647
Fair value deposits acquired	'	'	8,140
Fair value non-compete agreement acquired	'	'	27,917
Fair value goodwill acquired	1,422,670	1,422,670	1,422,670
Fair value liabilities assumed	'	'	-946,697
Fair value net assets purchased	'	'	$2,025,000

Business_Combination_Details_N

Business Combination (Details Narrative) (USD $)	3 Months Ended		12 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Dec. 31, 2012	Dec. 10, 2012
Business Combinations [Abstract]	'	'	'	'
Business combination, name of acquired entity	'	'	'Schuylkill Open MRI Inc	'
Business combination, description of acquired entity	'	'	'SMI provides Magnetic Resonance Imaging (MRI) services.	'
Business combination, date of acquisition	'	'	10-Dec-12	'
Business combination, capital lease agreement	'	'	'	$11,013
Business combination, one-time capital lease payment	'	'	'	125,000
Business combination, capital lease, value	'	'	'	555,000
Business combination, option to purchase equipment	'	'	'On December 10, 2012, the Company entered into a lease agreement with one of the sellers of SMI to lease the two MRI machines. Under the terms of the lease, SMI is to make monthly payments of $11,013, plus applicable sales tax, over a period of 48 months. In addition, SMI agreed to make a one-time lease payment of $125,000, which was paid by March 30, 2013. The Company has guaranteed all of SMI's obligations under the lease. At the end of the lease, SMI will have the option to purchase the MRI machines for a total purchase price of $1.00.	'
Business combination, revenue through acquired entity	457,965	476,016	'	'
Business combination, gross earnings through acquired entity	356,055	345,235	'	'
Business combination, costs related to the acquisition	'	'	$81,811	'

Goodwill_Details

Goodwill (Details) (USD $)	3 Months Ended	12 Months Ended
	Mar. 31, 2014	Dec. 31, 2013
Goodwill [Roll Forward]	'	'
Goodwill, balance at beginning of period	$1,422,670	$1,422,670
Changes in Goodwill	0	0
Goodwill, balance at end of period	$1,422,670	$1,422,670

Lease_Commitments_Details

Lease Commitments (Details) (USD $)	Mar. 31, 2014
Office Space	'
Expected Lease Commitments	'
Year 2014	$117,859
Year 2015	148,932
Year 2016	106,266
Servers	'
Expected Lease Commitments	'
Year 2014	23,328
Year 2015	31,104
Year 2016	31,104
Total Lease Commitments	'
Expected Lease Commitments	'
Year 2014	141,187
Year 2015	180,036
Year 2016	$137,370

Lease_Commitments_Details_Narr

Lease Commitments (Details Narrative) (USD $)	3 Months Ended
	Mar. 31, 2014
CTS - Office Space	'
Operating Leased Assets [Line Items]	'
Operating lease, minimum payments	$5,300
Leasing arrangements	'CTS has a lease commitment for its office space of approximately $2,450 minimum rental and approximately $2,850 in utilities, realty taxes and operating costs. The lease renewed in April 2013 for a period of five years and will expire in March 2018. On renewal, CTS was give a rental credit of approximately $28,000.
CTS - Off-site Servers	'
Operating Leased Assets [Line Items]	'
Operating lease, minimum payments	1,500
Leasing arrangements	'The lease expires on April 30, 2017
SMI - Off Site Server	'
Operating Leased Assets [Line Items]	'
Operating lease, minimum payments	1,092
SMI - Office Space - Pottsville, Pennsylvania	'
Operating Leased Assets [Line Items]	'
Operating lease, minimum payments	7,111
Leasing arrangements	'SMI entered into a lease commitment for its office space in Pottsville, Pennsylvania. The lease will expire on June 30, 2016 and is renewable for an additional term of 5 years.
SMI - Office Space - Dallas, Texas	'
Operating Leased Assets [Line Items]	'
Operating lease, minimum payments	$1,540
Leasing arrangements	'The lease expires on August 31, 2014

Accounts_Payable_and_Accrued_L1

Accounts Payable and Accrued Liabilities (Details Narrative) (USD $)	Mar. 31, 2014	Dec. 31, 2013
Trade Payables and Accrued Liabilities [Line Items]	'	'
Trade payables and accrued expenses	$539,910	$608,151
CTS - On-Going Operations	'	'
Trade Payables and Accrued Liabilities [Line Items]	'	'
Trade payables and accrued expenses	231,097	301,965
SMI - On-Going Operations	'	'
Trade Payables and Accrued Liabilities [Line Items]	'	'
Trade payables and accrued expenses	$278,443	$278,854

Obligations_Under_Capital_Leas2

Obligations Under Capital Lease (Details) (USD $)	Mar. 31, 2014
Capital Leases Future Minimum Payments Due Rolling Maturity	'
Minimum future lease payments, 2014	$99,115
Minimum future lease payments, 2015	132,152
Minimum future lease payments, 2016	132,150
Total minimum lease payments	363,417
Less amount representing interest	49,012
Present value of minimum lease payments	314,405
Less current portion of minimum lease payments	$104,009

Obligations_Under_Capital_Leas3

Obligations Under Capital Lease (Details Narrative) (USD $)	3 Months Ended
	Mar. 31, 2014
Leases, Capital [Abstract]	'
Capital leases, equipment, gross	$555,000
Capital leases, equipment, net	407,083
Capital leases, amortization expense	$27,750

Promissory_Notes_Details

Promissory Notes (Details) (USD $)	3 Months Ended	12 Months Ended
	Mar. 31, 2014	Dec. 31, 2013
Promissory Notes [Roll Forward]	'	'
Promissory notes, beginning of period	$45,015	$119,624
Proceeds from Notes Issuances	'	6,000
Accrued interest	593	6,616
Payments through end of period	-13,110	-87,225
Promissory notes, end of period	$32,498	$45,015

Promissory_Notes_Details_Narra

Promissory Notes (Details Narrative)	12 Months Ended
	Dec. 31, 2013
Other Liabilities Disclosure [Abstract]	'
Accrued interest rate, terms	'$18,736 of the notes assumed on acquisition represented by a promissory note accruing interest at an annual rate of 10.5% and paid out monthly. $45,792 of the notes assumed on acquisition represented by a promissory note accruing interest at an annual rate of 6% and paid out monthly.

Convertible_Notes_Details_1

Convertible Notes (Details 1) (USD $)	3 Months Ended
	Mar. 31, 2014
Series B - Note 1	'
Debt Instrument [Line Items]	'
Convertible note, issuance date	3-Dec-12
Convertible note, beginning balance	$25,000
Convertible note, accrued interest	750
Convertible note, payments	-750
Convertible note, amortization of debt discount	94
Convertible note, unamortized debt discount	-719
Convertible note, ending balance	24,375
Convertible note, maturity date	31-Dec-15
Series B - Note 2	'
Debt Instrument [Line Items]	'
Convertible note, issuance date	3-Dec-12
Convertible note, beginning balance	125,000
Convertible note, accrued interest	3,750
Convertible note, payments	-3,750
Convertible note, amortization of debt discount	1,244
Convertible note, unamortized debt discount	-10,569
Convertible note, ending balance	115,675
Convertible note, maturity date	31-Dec-15
Series B - Note 3	'
Debt Instrument [Line Items]	'
Convertible note, issuance date	3-Dec-12
Convertible note, beginning balance	50,000
Convertible note, accrued interest	1,500
Convertible note, payments	-1,500
Convertible note, amortization of debt discount	281
Convertible note, unamortized debt discount	-2,156
Convertible note, ending balance	48,125
Convertible note, maturity date	31-Dec-15
Series B - Note 4	'
Debt Instrument [Line Items]	'
Convertible note, issuance date	3-Dec-12
Convertible note, beginning balance	25,000
Convertible note, accrued interest	750
Convertible note, payments	-750
Convertible note, amortization of debt discount	94
Convertible note, unamortized debt discount	-719
Convertible note, ending balance	24,375
Convertible note, maturity date	31-Dec-15
Series B - Note 5	'
Debt Instrument [Line Items]	'
Convertible note, issuance date	3-Dec-12
Convertible note, beginning balance	25,000
Convertible note, accrued interest	750
Convertible note, payments	-750
Convertible note, amortization of debt discount	94
Convertible note, unamortized debt discount	-719
Convertible note, ending balance	24,375
Convertible note, maturity date	31-Dec-15
Series B - Note 6	'
Debt Instrument [Line Items]	'
Convertible note, issuance date	3-Dec-12
Convertible note, beginning balance	25,000
Convertible note, accrued interest	750
Convertible note, payments	-750
Convertible note, amortization of debt discount	94
Convertible note, unamortized debt discount	-719
Convertible note, ending balance	24,375
Convertible note, maturity date	31-Dec-15
Series B - Note 7	'
Debt Instrument [Line Items]	'
Convertible note, issuance date	3-Dec-12
Convertible note, beginning balance	1,500,000
Convertible note, accrued interest	45,000
Convertible note, payments	-45,000
Convertible note, amortization of debt discount	16,875
Convertible note, unamortized debt discount	-129,375
Convertible note, ending balance	1,387,500
Convertible note, maturity date	31-Dec-15
Series B - Note 8	'
Debt Instrument [Line Items]	'
Convertible note, issuance date	3-Dec-12
Convertible note, beginning balance	50,000
Convertible note, accrued interest	1,500
Convertible note, payments	-1,500
Convertible note, amortization of debt discount	281
Convertible note, unamortized debt discount	-2,156
Convertible note, ending balance	48,125
Convertible note, maturity date	31-Dec-15
Series B - Note 9	'
Debt Instrument [Line Items]	'
Convertible note, issuance date	3-Dec-12
Convertible note, beginning balance	15,000
Convertible note, accrued interest	450
Convertible note, payments	-450
Convertible note, amortization of debt discount	56
Convertible note, unamortized debt discount	-431
Convertible note, ending balance	14,625
Convertible note, maturity date	31-Dec-15
Series B - Note 10	'
Debt Instrument [Line Items]	'
Convertible note, issuance date	3-Dec-12
Convertible note, beginning balance	100,000
Convertible note, accrued interest	3,000
Convertible note, payments	-3,000
Convertible note, amortization of debt discount	856
Convertible note, unamortized debt discount	-7,081
Convertible note, ending balance	93,775
Convertible note, maturity date	31-Dec-15
Series B - Note 11	'
Debt Instrument [Line Items]	'
Convertible note, issuance date	27-Mar-13
Convertible note, beginning balance	25,000
Convertible note, accrued interest	750
Convertible note, payments	-750
Convertible note, amortization of debt discount	129
Convertible note, unamortized debt discount	-1,162
Convertible note, ending balance	23,967
Convertible note, maturity date	31-Mar-16
Series B - Note 12	'
Debt Instrument [Line Items]	'
Convertible note, issuance date	27-Mar-13
Convertible note, beginning balance	25,000
Convertible note, accrued interest	750
Convertible note, payments	-750
Convertible note, amortization of debt discount	129
Convertible note, unamortized debt discount	-1,162
Convertible note, ending balance	23,967
Convertible note, maturity date	31-Mar-16
Series B - Note 13	'
Debt Instrument [Line Items]	'
Convertible note, issuance date	27-Mar-13
Convertible note, beginning balance	25,000
Convertible note, accrued interest	750
Convertible note, payments	-750
Convertible note, amortization of debt discount	129
Convertible note, unamortized debt discount	-1,162
Convertible note, ending balance	$23,967
Convertible note, maturity date	31-Mar-16

Convertible_Notes_Details_2

Convertible Notes (Details 2) (USD $)	3 Months Ended	12 Months Ended
	Mar. 31, 2014	Dec. 31, 2013
Series B - Convertible Notes	'	'
Summary of Convertible Notes [Line Items]	'	'
Convertible notes, beginning of period	$2,015,000	$2,015,000
Less: unamortized debt discount	-137,775	-158,131
Convertible notes principal, net	1,877,225	1,856,869
Less: Payment in period	-60,450	-235,300
Added: Accrued interest	60,450	235,300
Total convertible notes, net	1,877,225	1,856,869
Long term portion, net	1,877,225	1,856,869
Individually Issued Convertible Note	'	'
Summary of Convertible Notes [Line Items]	'	'
Convertible notes, beginning of period	300,000	'
Less: unamortized debt discount	-25,500	'
Convertible notes principal, net	274,500	'
Added: Accrued interest	789	'
Total convertible notes, net	275,289	'
Less: Short term portion, net	54,900	'
Long term portion, net	$220,389	'

Convertible_Notes_Details_3

Convertible Notes (Details 3) (USD $)	3 Months Ended
	Mar. 31, 2014
Series B Notes - Long-Term Debt Maturities	'
Long Term Debt Maturities [Line Items]	'
Principal payments, 2014	$0
Principal payments, 2015	1,865,000
Principal payments, 2016	150,000
Principal payments, 2017	0
Principal payments, 2018	0
Interest payments, 2014	181,350
Interest payments, 2015	241,800
Interest payments, 2016	4,500
Interest payments, 2017	0
Interest payments, 2018	0
Amortization expense, 2014	61,069
Amortization expense, 2015	75,156
Amortization expense, 2016	1,550
Amortization expense, 2017	0
Amortization expense, 2018	0
Non-Affiliate Issued Convertible Note	'
Long Term Debt Maturities [Line Items]	'
Principal payments, 2014	35,000
Principal payments, 2015	60,000
Principal payments, 2016	60,000
Principal payments, 2017	145,000
Interest payments, 2014	23,803
Interest payments, 2015	28,496
Interest payments, 2016	21,360
Interest payments, 2017	4,103
Interest payments, 2018	0
Amortization expense, 2014	6,375
Amortization expense, 2015	8,500
Amortization expense, 2016	8,500
Amortization expense, 2017	2,125
Amortization expense, 2018	$0

Convertible_Notes_Details_Narr

Convertible Notes (Details Narrative) (USD $)	12 Months Ended	3 Months Ended
	Dec. 31, 2013	Mar. 31, 2014
	Convertible Notes - Series B	Individual - ConvertibleNote
Convertible Notes Series [Line Items]	'	'
Convertible notes, sold	$150,000	$300,000
Convertible notes, payment terms	'Series B Notes pay interest at a rate of 12% per annum, payable to the holder at 1% per month.	'The note pays interest at a rate of 12% per annum, payable to the holder at 1% per month. The Company will also be making monthly payments of $5,000 towards the principal balance beginning June 1, 2014 for 3 years until the note due date of February 27, 2017.
Convertible notes, price per share for conversion of shares of common stock	$0.10	$0.15
Note holder additions	'	'The non-affiliate will receive 300,000 shares as part of the note agreement.
Additional paid in capital and discount	244,275	'
Private placement, 12% convertible notes (Series B Notes), principal amount	$1,865,000	'
Private placement, maturity date	31-Mar-16	'
Common stock issued	5,315,000	'

Related_Party_Transactions_Det

Related Party Transactions (Details) (USD $)	3 Months Ended
	Mar. 31, 2014	Jun. 30, 2010
Related Party Transactions [Roll Forward]	'	'
Shareholder note, beginning balance	$7,062	'
Shareholder note, accrued interest	0	'
Shareholder note, foreign exchange loss	0	'
Shareholder note, payments	-7,062	'
Shareholder note, ending balance	0	42,944
Shareholder convertible note, beginning balance	10,936	'
Shareholder convertible note, accrued interest	48	'
Shareholder convertible note, foreign exchange gain	693	'
Shareholder convertible note, payments	-10,291	'
Shareholder convertible note, ending balance	$0	'

Related_Party_Transactions_Det1

Related Party Transactions (Details Narrative) (USD $)	Mar. 31, 2014	Jun. 30, 2010
Related Party Transactions [Abstract]	'	'
Related party loan	$0	$42,944

Major_Customers_Details

Major Customers (Details) (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Major Customers [Line Items]	'	'
Major customer percent of revenue	40.00%	70.00%
Contract A	'	'
Major Customers [Line Items]	'	'
Major customer revenues	260,873	281,675
Major customer percent of revenue	22.00%	22.00%
Major customers accounts receivable closing balance	18,914	17,876
Major customers accounts receivable percentage	6.00%	6.00%
Contract E	'	'
Major Customers [Line Items]	'	'
Major customer revenues	205,727	293,092
Major customer percent of revenue	17.00%	23.00%
Major customers accounts receivable closing balance	51,614	95,552
Major customers accounts receivable percentage	17.00%	34.00%
Contract F	'	'
Major Customers [Line Items]	'	'
Major customer revenues	132,972	138,625
Major customer percent of revenue	11.00%	11.00%
Major customers accounts receivable closing balance	44,176	46,796
Major customers accounts receivable percentage	15.00%	17.00%
Contract G	'	'
Major Customers [Line Items]	'	'
Major customers accounts receivable closing balance	13,034	12,382
Major customers accounts receivable percentage	4.00%	4.00%
Contract H	'	'
Major Customers [Line Items]	'	'
Major customer revenues	74,408	62,899
Major customer percent of revenue	6.00%	5.00%
Major customers accounts receivable closing balance	25,097	54,757
Major customers accounts receivable percentage	8.00%	19.00%

Major_Vendors_Details_Narrativ

Major Vendors (Details Narrative) (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Major Vendors	'	'
Expenses for system software and support	$13,455	$15,165

Common_Stock_Transactions_Deta

Common Stock Transactions (Details Narrative) (USD $)	3 Months Ended	12 Months Ended
	Mar. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Equity [Abstract]	'	'	'
Shares issued, convertible notes, shares	300,000	300,000	5,015,000
Shares issued, convertible notes, value	$25,500	$18,600	$225,675
Shares issued for services, shares	5,000	'	'
Shares issued for services, value	$150	'	'

Going_Concern_Details_Narrativ

Going Concern (Details Narrative) (USD $)	Mar. 31, 2014
Going Concern	'
Working capital deficit	$289,774

Subsequent_Event_Details_Narra

Subsequent Event (Details Narrative) (Subsequent Event, Convertible Notes to Non-Affiliates, USD $)	Apr. 30, 2014
Subsequent Event | Convertible Notes to Non-Affiliates	'
Subsequent Events [Line Items]	'
Convertible notes issued, value	$75,000